Harmony Biosciences Holdings, Inc. (HRMY) Stock Ticker
HRMY right now
Market factors today
Unlock the full HRMY picture
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in 2017, was formerly known as Harmony Biosciences II, Inc. before adopting its current name in February 2020. Harmony Biosciences Holdings, Inc. operates out of Plymouth Meeting, Pennsylvania.
HRMY stock facts
| Ticker symbol | HRMY |
| Exchange | NASDAQ Global Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $2.4B |
| CEO | Jeffrey Dayno |
| Employees | 293 |
| Headquarters | Plymouth Meeting, PA, US |
| IPO date | 2020-08-19 |
| Website | www.harmonybiosciences.com |
What you can see for HRMY on Tickr
Live HRMY price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the HRMY report.
Rankings
FAQ
What is the ticker symbol for Harmony Biosciences Holdings, Inc.?
The ticker symbol for Harmony Biosciences Holdings, Inc. is HRMY, listed on the NASDAQ Global Market.
What is HRMY?
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical firm dedicated to developing and marketing therapies for individuals in the United States who suffer from rare neurological conditions. Their flagship product, WAKIX, is a prescription medication designed to treat excessive daytime sleepiness in adult patients diagnosed with narcolepsy. The company, which was founded in…